Zobrazeno 1 - 10
of 17
pro vyhledávání: '"S. R. Aravind"'
Autor:
S. Nishanth Kumar, S. R. Aravind, Jubi Jacob, Geethu Gopinath, Ravi S. Lankalapalli, T.T. Sreelekha, B.S. Dileep Kumar
Publikováno v:
Frontiers in Microbiology, Vol 7 (2016)
In continuation of our search for new bioactive compounds from soil microbes, a fluorescent Pseudomonas strain isolated from paddy field soil of Kuttanad, Kerala, India was screened for the production of bioactive secondary metabolites. This strain w
Externí odkaz:
https://doaj.org/article/e8cc2ad355154776967aec1785a49402
Publikováno v:
The Scientific World Journal, Vol 2012 (2012)
Antitumor activity of polysaccharide PST001 isolated from the seed kernel of Tamarindus indica was evaluated using different cancer cell lines. Human cancer cell lines A549, KB, and MCF-7 and murine cancer cell lines DLA and EAC were treated with PST
Externí odkaz:
https://doaj.org/article/ed29645fa1564995b06714d653b6cfe3
Autor:
S. R. Aravind, Kiran P. Singh, Liliia Mogylnytska, Alsu G. Zalevskaya, Beata Matyjaszek-Matuszek, Karin Wernicke-Panten, My-Liên Nguyên-Pascal, Suzanne Pierre, Baerbel Rotthaeuser, Daniel Kramer, Bhaswati Mukherjee
Publikováno v:
Diabetes Therapy. 13:1299-1310
We compared the efficacy, safety, and immunogenicity of biosimilar insulin aspart premix SAR341402 Mix 70/30 (70% intermediate SAR341402 protamine and 30% rapid SAR341402 solution) (SARThis phase 3, randomized, open-label, multinational, 26-week tria
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0caa3cbb19b79639d8e3fe739120f26b
https://doi.org/10.1007/s13300-022-01279-z
https://doi.org/10.1007/s13300-022-01279-z
Autor:
Ashok Kumar Das, Banshi Saboo, Rajeev Chawla, S. R. Aravind, Rajesh Rajput, Awadhesh K. Singh, J. J. Mukherjee, Ashok Jhingan, Parag Shah, Vaishali Deshmukh, Shailaja Kale, Shalini Jaggi, G. R. Sridhar, Rajnish Dhediya, Kumar Gaurav
Publikováno v:
International Journal of Diabetes in Developing Countries.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0fa25577fa68d36fc71efe323d7b3fbf
https://doi.org/10.1007/s13410-023-01192-6
https://doi.org/10.1007/s13410-023-01192-6
Autor:
Viswanathan, Mohan, Wolfgang, Schmider, Kiran P, Singh, Baerbel, Rotthaeuser, Bhaswati, Mukherjee, S R, Aravind
Publikováno v:
Indian journal of endocrinology and metabolism. 26(4)
We compared the pharmacokinetic exposure, efficacy, safety and immunogenicity of biosimilar insulin aspart premix SAR341402 Mix 70/30 (SARThis was a randomized, open-label, parallel-group, substudy of the phase 3 GEMELLI M trial performed in three In
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::907a679ad50e5ec5094be3eb23d0a403
https://pubmed.ncbi.nlm.nih.gov/36185965
https://pubmed.ncbi.nlm.nih.gov/36185965
Autor:
S. R. Aravind, Kiran P. Singh, Grace Aquitania, Liliia Mogylnytska, Alsu G. Zalevskaya, Beata Matyjaszek-Matuszek, Karin Wernicke-Panten, My-Liên Nguyên-Pascal, Suzanne Pierre, Baerbel Rotthaeuser, Daniel Kramer, Bhaswati Mukherjee
Publikováno v:
Diabetes therapy : research, treatment and education of diabetes and related disorders. 13(5)
This study compared the efficacy, safety, and immunogenicity of biosimilar insulin aspart premix SAR341402 Mix 70/30 (SARThis 26-week, open-label, phase 3 trial enrolled 402 people with T1D (n = 105) or T2D (n = 297) previously treated with premix in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bebbeff4fe4b05ba639824f46cddc001
https://pubmed.ncbi.nlm.nih.gov/35420397
https://pubmed.ncbi.nlm.nih.gov/35420397
Autor:
A G, Unnikrishnan, Banshi, Saboo, Shashank, Joshi, Jothydev, Kesavadev, B M, Makkar, Sanjay, Agarwal, S R, Aravind, Krishna, Seshadri, Manoj, Chawla, Neeta, Deshpande, Rajeev, Chawla, Mangesh, Tiwaskar
Publikováno v:
The Journal of the Association of Physicians of India. 67(11)
Glucose monitoring is an important aspect of diabetes care. The traditional methodologies of blood glucose monitoring such as fasting plasma glucose, post prandial glucose, glycosylated hemoglobin and self-monitoring of blood glucose do not adequatel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f528af4ddb8a5f7841f673c53037c7a0
https://pubmed.ncbi.nlm.nih.gov/31793278
https://pubmed.ncbi.nlm.nih.gov/31793278
Autor:
Sujoy Ghosh, Sarita Bajaj, Purushottam Chatterjee, Sanjay Agarwal, S. R. Aravind, Rajeev Chawla, Sunil Gupta, J. Jayaprakashsai, Sanjay Kalra, Ch Vasanth Kumar, Anuj Maheshwari, B. M. Makkar, C. R. Anand Moses, Jayant Panda, Vijay Panikar, P. V. Rao, Banshi Saboo, Rakesh Sahay, K. R. Narasimha Setty, Vijay Viswanathan
Publikováno v:
International Journal of Diabetes in Developing Countries. 38:4-10
This article encapsulates pragmatic advice that is necessary to ensure safe travel for people with diabetes. Written in simple words, it empowers the primary care physician to answer questions that are frequently asked by patients planning travel. It
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7528064d3f1c1a356b4dd5ed625eac11
https://doi.org/10.1007/s13410-018-0605-6
https://doi.org/10.1007/s13410-018-0605-6
Autor:
April Slee, Dick De Zeeuw, Kenneth W. Mahaffey, Harold Bays, S. R. Aravind, Rafael Violante, Luc Van Gaal, David R. Matthews, Wayne Shaw, Naresh Aggarwal
Publikováno v:
Diabetes, 67. AMER DIABETES ASSOC
Overweight and obesity increases the risk of heart and kidney disease. The effects of canagliflozin (CANA) in patients with BL BMI Disclosure H. Bays: Research Support; Self; Amgen Inc. L. Van Gaal: Advisory Panel; Self; Astra Zeneca, Boehringer Inge
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::04762dc968f0d5c52184dc29019b82aa
https://doi.org/10.2337/db18-1206-p
https://doi.org/10.2337/db18-1206-p
Autor:
Rajiv, Kovil, Manoj, Chawla, Rajesh, Rajput, A K, Singh, Binayak, Sinha, Samit, Ghosal, Piya, Ballani, Sunil, Gupta, Snehal, Tanna, S M, Bandukwala, Tejas, Shah, Vijay, Negalur, Anil, Bhoraskar, S R, Aravind, Abdul H, Zargar, Jothydev, Kesavadev, Ashok Kumar, Das
Publikováno v:
The Journal of the Association of Physicians of India. 65(2)
Insulin is the oldest of the currently available treatment options in Type 2 diabetes mellitus (T2DM) and is considered as the most effective glucose lowering agent. Despite this, decision on starting insulin therapy is often delayed in India as well
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::cd89096fe2c9d441e78bae88f654c07a
https://pubmed.ncbi.nlm.nih.gov/30341886
https://pubmed.ncbi.nlm.nih.gov/30341886